Differential mRNA Expression of Urokinase-Type Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor Type-2 in Normal Human Endometria and Endometrial Carcinomas

This publication has 19 references indexed in Scilit:

• Induction of Vascular SMC Proliferation by Urokinase Indicates a Novel Mechanism of Action in Vasoproliferative Disorders
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Tumor-Associated Proteolytic Factors uPA and PAI-1 in Endometrial Carcinoma
  Gynecologic Oncology, 1997
• Expression of Urokinase-Type Plasminogen Activator and Its Receptor during Ovarian Follicular Development¹
  Endocrinology, 1997
• Presence of Urokinase Plasminogen Activator and Plasminogen Activator Inhibitor-1 Messenger Ribonucleic Acids in Rat Endometrium during Decidualization in Vivo1
  Biology of Reproduction, 1996
• Receptor‐mediated endocytosis of plasminogen activators and activator/inhibitor complexes
  FEBS Letters, 1994
• Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas
  British Journal of Cancer, 1994
• Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites
  American Journal of Obstetrics and Gynecology, 1994
• Direct Stimulation of Urokinase, Plasmin, and Collagenase by Meperidine: A Possible Mechanism for the Ability of Meperidine to Enhance Cervical Effacement and Dilation
  American Journal of Perinatology, 1993
• The plasminogen activator urokinase and its inhibitor PAI-2 in endometrial cancer
  Gynecologic Oncology, 1992
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
  Biochemistry, 1979